Profile picture

Doctor Davide Stolfo

Hospital Santa Maria della Misericordia, Udine (Italy)
Membership: HFA Member
Follow
Biography
Davide Stolfo is an Italian cardiologist working in the CCU of the Cattinara Hospital in Trieste (Italy). He is part of the “Outpatient Clinic for HF and genetic cardiomyopaties” and coordinates the activity of the “PH Outpatient Clinic”. He is also part of the ECMO team and member of the roundtable of his region for advanced heart failure – patients selection for MCS – ECLS. He graduated at the University of Trieste (2008) and completed Cardiology residency in Trieste in 2014. He also had clinical experience as clinical and research fellow at the Royal Brompton Hospital (London, UK), Harefield Hospital (London, UK) and Stanford University (Palo Alto, CA – USA). In 2017 he got the title of HF specialist from the University of Zurich, the HFA-ESC. He completed his PhD at the Karolinska Institutet (Stockholm, Sweden) on June 2022. He has published/presented several articles on top peer reviewed journals as first author/coauthor and in international congresses.
Logo ESC

Contributor content

Pharmacoepidemiology of heart failure: how well is guideline-directed medical therapy implemented today?
Presentation
Pharmacoepidemiology of heart failure: how well is guideline-directed medical therapy implemented today?
Incidence of cancer in heart failure across ejection fraction phenotypes and sexes: a nationwide cohort analysis
Presentation
Incidence of cancer in heart failure across ejection fraction phenotypes and sexes: a nationwide cohort analysis
Sex differences in the prognostic role of achieving target doses of heart failure with reduced ejection fraction medications: data from the Swedish Heart Failure Registry
Presentation
Sex differences in the prognostic role of achieving target doses of heart failure with reduced ejection fraction medications: data from the Swedish Heart Failure Registry
Real-world use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry
Presentation
Real-world use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry
How to maintain optimised drug therapy in the multimorbid patient
Presentation
How to maintain optimised drug therapy in the multimorbid patient
Burden and predictors of non-cardiovascular mortality and morbidity events in advanced heart failure
Presentation
Burden and predictors of non-cardiovascular mortality and morbidity events in advanced heart failure
Persistent high burden of heart failure across the ejection fraction spectrum: data from the Swedish heart failure registry
Presentation
Persistent high burden of heart failure across the ejection fraction spectrum: data from the Swedish heart failure registry
Use of heart failure evidence-based therapy across age strata: data from the Swedish Heart Failure Registry
Presentation
Use of heart failure evidence-based therapy across age strata: data from the Swedish Heart Failure Registry
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation
Presentation
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation
Genetic risks for arrhythmia phenotypes in dilated cardiomyopathy
Presentation
Genetic risks for arrhythmia phenotypes in dilated cardiomyopathy

ESC 365 is supported by